Logo do repositório
 
Publicação

Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management

dc.contributor.authorBrito, Miguel
dc.contributor.authorGinete, Catarina
dc.contributor.authorOfakunrin, Akinyemi
dc.contributor.authorDiaku-Akinwumi, Ijeoma
dc.contributor.authorInusa, Baba Psalm Duniya
dc.date.accessioned2025-06-03T13:44:54Z
dc.date.available2025-06-03T13:44:54Z
dc.date.issued2025
dc.description© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.pt_PT
dc.description.abstractIntroduction: The management of Sickle cell disease (SCD) in sub-Saharan Africa (SSA) suffers from the lack of universal infant and population screening, inadequate access to standard treatment and poor public health prioritization amidst unstable political systems. Areas covered: The state of evidencebased management of SCD in SSA was investigated including sustainability of international funding agencies. Expert opinion: Current efforts are fragmentary along languages lines; sometimes driven by the funder's objectives and not the national agenda. The review highlighted the role of internal and external partnerships such as SPARCO, ARISE, CONSA, as well as technology-based support for the implementation of evidence-based care for SCD. We advocate for increased funding to implement SCD comprehensive care in line with the WHO SCD Framework for Primary, Secondary, Tertiary and Specialist Comprehensive Care at state and national level. To achieve this objective, it is important that SCD, as a leading non-communicable disease in Africa, be mandated as a standing agenda for the National Council of Ministers at the African Union, WHO and other regional bodies in Africa.pt_PT
dc.description.sponsorshipAuthors acknowledge the benefit of the ARISE project, which received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 824021.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationExpert Rev Hematol. 2025 Jun;18(6):447-462pt_PT
dc.identifier.doi10.1080/17474086.2025.2500599pt_PT
dc.identifier.eissn1747-4094
dc.identifier.issn1747-4086
dc.identifier.urihttp://hdl.handle.net/10400.5/101228
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherTaylor & Francispt_PT
dc.relationAfrican Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement
dc.relation.publisherversionhttps://www.tandfonline.com/journals/ierr20pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectSickle cell diseasept_PT
dc.subjectSub-Saharan Africapt_PT
dc.subjectAnemiapt_PT
dc.subjectAntimalarial prophylaxispt_PT
dc.subjectBlood transfusionpt_PT
dc.subjectGenetic counselingpt_PT
dc.subjectHealth financingpt_PT
dc.subjectHydroxyureapt_PT
dc.subjectMalaria prophylaxispt_PT
dc.subjectNewborn screeningpt_PT
dc.subjectPpenicillin Vpt_PT
dc.titleTreating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based managementpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumber824021
oaire.awardTitleAfrican Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/824021/EU
oaire.citation.endPage462pt_PT
oaire.citation.issue6pt_PT
oaire.citation.startPage447pt_PT
oaire.citation.titleExpert Review of Hematologypt_PT
oaire.citation.volume18pt_PT
oaire.fundingStreamH2020
person.familyNameHonrado Ginete
person.givenNameAna Catarina
person.identifier.ciencia-id8715-F62E-1E0F
person.identifier.orcid0000-0002-2334-782X
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationbfce12d3-de7f-4ef6-b915-d7abe362c8c1
relation.isAuthorOfPublication.latestForDiscoverybfce12d3-de7f-4ef6-b915-d7abe362c8c1
relation.isProjectOfPublication17b0e605-e2b3-4d93-8006-d6693a0fba33
relation.isProjectOfPublication.latestForDiscovery17b0e605-e2b3-4d93-8006-d6693a0fba33

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Treating_sickle.pdf
Tamanho:
3.31 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: